The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Analgesics in Patients with Hepatic Impairment: Pharmacology and Clinical Implications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126 · cited 1×
“Evidence-based guidelines suggest the use of antidepressants and anticonvulsants as first-line neuropathic pain treatment.([178,179]) Studies evaluating the disposition, safety and efficacy of neuropathic pain drugs in patients with hepatic impairment are often lacking.”
BackgroundEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib: A Selective Cyclo-Oxygenase-2 Inhibitor
Davies, N. M., McLachlan, A. J., Day, R. O., & Williams, K. M. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038030-00003 · Cited by 424
Nguyen, G. C., Sam, J., & Thuluvath, P. J. (2008) · Hepatology · doi:10.1002/hep.22536 · Cited by 107 · cited 1×
“Alcoholic liver disease, non-alcoholic fatty liver disease and hepatitis C virus infection were detected as risk factors for the development of acute liver injury, severe liver failure or increased mortality following paracetamol overdose.([66,67]) These studies render attentive to the higher vulnerability of this pop…”
BackgroundMyers, R. P., & Shaheen, A. A. M. (2009) · Hepatology · doi:10.1002/hep.22798 · Cited by 36 · cited 2×
“remains unclear whether therapeutic doses of paracetamol would be more toxic in patients with chronic liver disease or cirrhosis.([66,68]) A double-blind, two-period, crossover study was conducted in 20 patients with chronic liver disease to analyse the development of adverse Table I.”
Background
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,305
Trends in Tramadol: Pharmacology, Metabolism, and Misuse
Miotto, K., Cho, A. K., Khalil, M. A., Blanco, K., Sasaki, J. D., & Rawson, R. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001683 · Cited by 354
Opioid misuse in gastroenterology and non-opioid management of abdominal pain
Szigethy, E., Knisely, M., & Drossman, D. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.141 · Cited by 117
Alchin, J., Dhar, A., Siddiqui, K., & Christo, P. J. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2049551 · Cited by 65
Metadata
- Authors
- Bosilkovska, M., Walder, B., Besson, M., Daali, Y., & Desmeules, J.
- Venue
- Drugs
- Published
- 2012-08
- Volume
- 72
- Issue
- 12
- Pages
- 1645-1669
- ISSN
- 0012-6667 (ISSN-L)
- OpenAlex
- W43632364
- Cited by
- 199
- References
- 6
- FWCI
- 14.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analgesics in Patients with Hepatic Impairment: Pharmacology and Clinical Implications. https://app.cochat.ai/papers/10.2165/11635500-000000000-00000
- The paper
- Bosilkovska, M., Walder, B., Besson, M., Daali, Y., & Desmeules, J. (2012). Analgesics in Patients with Hepatic Impairment: Pharmacology and Clinical Implications. Drugs. https://doi.org/10.2165/11635500-000000000-00000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.